Cargando…

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

BACKGROUND: DNA damage repair (DDR) plays a role in the tumorigenesis and progression of lung squamous cell carcinoma (LUSC), but the predictive value of DDR in LUSC has not been fully elucidated. METHODS: The LUSC datasets were retrieved from the Cancer Genome Atlas databases. Univariate Cox regres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Bin, Gong, Ting, Sun, Bingsheng, Zhang, Zhenfa, Zhong, Diansheng, Wang, Changli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013644/ https://www.ncbi.nlm.nih.gov/pubmed/35293140 http://dx.doi.org/10.1111/1759-7714.14370

Ejemplares similares

DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma
por: Wang, Xinshu, et al.
Publicado: (2022)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis
por: Wang, Xue-quan, et al.
Publicado: (2021)

Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma
por: Zhou, Hong, et al.
Publicado: (2022)

Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment
por: Gong, Ting, et al.
Publicado: (2022)

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer
por: Zhang, Linlin, et al.
Publicado: (2019)

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2022)

A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis
por: Zhan, Jiaoyang, et al.
Publicado: (2021)

Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer
por: Song, Dingli, et al.
Publicado: (2022)

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021)

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer
por: Li, Ling, et al.
Publicado: (2022)

Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis
por: Yan, Yubo, et al.
Publicado: (2020)

miR-195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF
por: Liu, Hailin, et al.
Publicado: (2019)

Mutational signatures are jointly shaped by DNA damage and repair
por: Volkova, Nadezda V., et al.
Publicado: (2020)

Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer
por: Chang, Yiming, et al.
Publicado: (2023)

DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma
por: Lu, Yongpan, et al.
Publicado: (2023)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients
por: Lv, Min-Yi, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma
por: Yang, Xiongtao, et al.
Publicado: (2020)

Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma
por: Li, Yang, et al.
Publicado: (2022)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
por: Li, Tianhang, et al.
Publicado: (2023)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features
por: Gu, Liyan, et al.
Publicado: (2022)

HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair
por: Zhou, Ting, et al.
Publicado: (2019)

A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma
por: Yang, Qin, et al.
Publicado: (2022)

Identification of Potential Prognostic Biomarkers Associated with Monocyte Infiltration in Lung Squamous Cell Carcinoma
por: Liu, Hailin, et al.
Publicado: (2022)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
por: Liang, Liping, et al.
Publicado: (2022)

Tumor‐associated macrophages (TAMs)‐derived osteopontin (OPN) upregulates PD‐L1 expression and predicts poor prognosis in non‐small cell lung cancer (NSCLC)
por: Li, Yue, et al.
Publicado: (2021)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2021)

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center
por: Zhu, Jianquan, et al.
Publicado: (2021)

A prognostic 11-DNA methylation signature for lung squamous cell carcinoma
por: Zhang, Jianlei, et al.
Publicado: (2020)

A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

Identification of a progression-associated long non-coding RNA signature for predicting the prognosis of lung squamous cell carcinoma
por: Wang, Yanyan, et al.
Publicado: (2018)

A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
por: Chi, Hao, et al.
Publicado: (2022)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
por: Yue, Dongsheng, et al.
Publicado: (2014)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
por: Yao, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dqm4bjtgnnds55m119p75b6f0